Company / EPS (Diluted)
Harmony Biosciences Holdings, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.13
FY2025
5-year range
-$24.07 / $2.97
FY2021-FY2025
Trend
-28.3%
vs FY2024
Sector context
#24 of 204
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s eps (diluted) of $2.13 is higher than 88% of companies in the Health Care sector (FY2025). Improved from $0.58 to $2.13 over the past 2 years.
Based on SEC 10-K filings.
2.13 in FY2025. Top quartile in the Health Care sector.
Improved from $0.58 to $2.13 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 204This company $2.13 Sector average -$0.98
▼
+317.4% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 28.3% year-over-year.
- Ranks #24 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.13 | -28.3% |
| FY2024 | $2.97 | +412.1% |
| FY2023 | $0.58 | +123.4% |
| FY2022 | -$2.48 | +89.7% |
| FY2021 | -$24.07 | +0.0% |
| FY2020 | -$24.07 | +0.0% |
| FY2019 | -$24.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026